secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2025-02-06T23:59:59+00:00
Accession:  0001193125-25-021763
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma reprices 6.76M underwater stock options to $1.34 per share
------------------------------------------------------------------------

- Board reduces exercise price to $1.34 for options with original prices from $1.36 to $44.96.
- Repricing applies to continuing employees; CEO's 2.13M options repriced (avg $4.30).
- Options may not be exercised at reduced price before February 3, 2026 retention end.
- CSO Tirtha Chakraborty and CMO Eyal Attar also have options repriced.
- Move intended to retain and motivate employees without additional equity or cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525021763/0001193125-25-021763-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525021763/d921842d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-021763

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer